Author Kaiser, Lena
-
2019 | Journal Article
In response to: The validity of 18F-GE180 as a TSPO imaging agent
Albert, N. L.; Unterrainer, M.; Brendel, M.; Kaiser, L.; Zweckstetter, M.; Cumming, P. & Bartenstein, P. (2019)
European Journal of Nuclear Medicine and Molecular Imaging, 46(6) pp. 1208-1211. DOI: https://doi.org/10.1007/s00259-019-04294-8
Details DOI
-
2019 | Journal Article | Research Paper |
Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau
Brendel, M.; Deussing, M.; Blume, T.; Kaiser, L.; Probst, F.; Overhoff, F. & Peters, F. et al. (2019)
Alzheimer's Research & Therapy, 11(1). DOI: https://doi.org/10.1186/s13195-019-0522-z
Details DOI
-
2021 | Journal Article | Research Paper
TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathy
Mahler, C.; Schumacher, A.-M.; Unterrainer, M.; Kaiser, L.; Höllbacher, T.; Lindner, S. & Havla, J. et al. (2021)
Brain: A Journal of Neurology, 144(9) pp. 2683-2695. DOI: https://doi.org/10.1093/brain/awab127
Details DOI PMID PMC